South San Francisco

10–100 Companies
Companies
59
Growing
Deals 2021 Q4
No investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
MedCity News

Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Substantially Fell Today

Pulse 2.0

Sutro Biopharma Stock (STRO): Why The Price Increased Today

Pulse 2.0

Calithera Biosciences (CALA) Stock: Why The Price Jumped Today

MedCity News

Theravance’s lead drug fails in Phase 3, triggers a restructuring cutting 75% of staff

$12,000,000 Venture capital (Series A)
neurons.AI

Mindera Raises Over $12 Million Series A-2 Financing

neurons.AI

insitro raises $400M for machine learning-powered drug discovery efforts

$400,000,000 Venture capital (Series C)
neurons.AI

insitro raises $400M for machine learning-powered drug discovery efforts

neurons.AI

insitro Raises $400 Million in Series C Financing

neurons.AI

insitro Raises $400 Million in Series C Financing

neurons.AI

BMS joins forces with insitro to develop neurodegenerative treatments

neurons.AI

insitro Bolsters Machine–Learning Platform with Haystack Sciences Acquisition

neurons.AI

Koller’s insitro snaps up Haystack to build up machine learning tech

$140,000,000 Venture capital (Series D)
TechCrunch

Plenty has raised over $500 million to grow fruits and veggies indoors

Xconomy

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

Xconomy

Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More

$270,000,000 Venture capital (Series C)
FinSMEs , ChinaMoneyNetwork

Freenome Closes $270M Series C Financing

Xconomy

Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug

Xconomy

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia